Curcumin inhibits angiotensin II-induced inflammation and proliferation of rat vascular smooth muscle cells by elevating PPAR-γ activity and reducing oxidative stress

International Journal of Molecular Medicine

Volumn 39, Issue 5, 2017, Pages 1307-1316

  Li, Hai Yu ^a   Yang, Mei ^b   Li, Ze ^a   Meng, Zhe ^a  

^a THE FIRST AFFILIATED HOSPITAL OF ZHENGZHOU UNIVERSITY   (China)

^b SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Angiotensin II; Curcumin; Inflammation; Oxidative stress; Peroxisome proliferator activated receptor

Indexed keywords

2 CHLORO 5 NITROBENZANILIDE; ANGIOTENSIN II; CURCUMIN; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 6; MESSENGER RNA; NITRIC OXIDE; P47PHOX PROTEIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; TUMOR NECROSIS FACTOR; UNCLASSIFIED DRUG; ANTIINFLAMMATORY AGENT; CYTOKINE; FREE RADICAL; NEUTROPHIL CYTOSOLIC FACTOR 1;

ANIMAL CELL; ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; ANTIPROLIFERATIVE ACTIVITY; ARTICLE; CONTROLLED STUDY; INFLAMMATION; MALE; NONHUMAN; OXIDATIVE STRESS; PROTEIN EXPRESSION; RAT; VASCULAR SMOOTH MUSCLE CELL; ANIMAL; CELL PROLIFERATION; DRUG EFFECTS; GENETICS; METABOLISM; SMOOTH MUSCLE CELL; VASCULAR SMOOTH MUSCLE;

ANGIOTENSIN II; ANIMALS; ANTI-INFLAMMATORY AGENTS; CELL PROLIFERATION; CURCUMIN; CYTOKINES; FREE RADICALS; MUSCLE, SMOOTH, VASCULAR; MYOCYTES, SMOOTH MUSCLE; NADPH OXIDASE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE II; OXIDATIVE STRESS; PPAR GAMMA; RATS; REACTIVE OXYGEN SPECIES;

EID: 85018775197     PISSN: 11073756     EISSN: 1791244X     Source Type: Journal    
DOI: 10.3892/ijmm.2017.2924     Document Type: Article

References (49)

1. Jiang G, Wang D, Li W, Pan Y, Zheng W, Zhang H and Sun YV: Coronary heart disease mortality in China: Age, gender, and urban-rural gaps during epidemiological transition. Rev Panam Salud Publica 31: 317-324, 2012.
2. Bäck M and Hansson GK: Anti-inflammatory therapies for atherosclerosis. Nat Rev Cardiol 12: 199-211, 2015.
3. Libby P: Inflammation in atherosclerosis. Arterioscler Thromb Vasc Biol 32: 2045-2051, 2012.
4. Chistiakov DA, Orekhov AN and Bobryshev YV: Vascular smooth muscle cell in atherosclerosis. Acta Physiol (Oxf) 214: 33-50, 2015.
5. Meng Z, Yan C, Deng Q, Gao DF and Niu XL: Curcumin inhibits LPS-induced inflammation in rat vascular smooth muscle cells in vitro via ROS-relative TLR4-MAPK/NF-κB pathways. Acta Pharmacol Sin 34: 901-911, 2013.
6. Pacurari M, Kafoury R, Tchounwou PB and Ndebele K: The renin-angiotensin-aldosterone system in vascular inflammation and remodeling. Int J Inflam 2014: 689360, 2014.
7. Askari AT, Shishehbor MH, Kaminski MA, Riley MJ, Hsu A and Lincoff AM; GUSTO-V Investigators: The association between early ventricular arrhythmias, renin-angiotensin-aldosterone system antagonism, and mortality in patients with ST-segment-elevation myocardial infarction: insights from Global Use of Strategies to Open Coronary Arteries (GUSTO) V. Am Heart J 158: 238-243, 2009.
8. Derosa G and Maffioli P: Peroxisome proliferator-activated receptor-γ (PPAR-γ) agonists on glycemic control, lipid profile and cardiovascular risk. Curr Mol Pharmacol 5: 272-281, 2012.
9. Usuda D and Kanda T: Peroxisome proliferator-activated receptors for hypertension. World J Cardiol 6: 744-754, 2014.
10. Fuentes E, Guzmán-Jofre L, Moore-Carrasco R and Palomo I: Role of PPARs in inflammatory processes associated with metabolic syndrome (Review). Mol Med Rep 8: 1611-1616, 2013.
11. Liu WX, Wang T, Zhou F, Wang Y, Xing JW, Zhang S, Gu SZ, Sang LX, Dai C and Wang HL: Voluntary exercise prevents colonic inflammation in high-fat diet-induced obese mice by up-regulating PPAR-gamma activity. Biochem Biophys Res Commun 459: 475-480, 2015.
12. Marchesi C, Rehman A, Rautureau Y, Kasal DA, Briet M, Leibowitz A, Simeone SM, Ebrahimian T, Neves MF, Offermanns S, et al: Protective role of vascular smooth muscle cell PPARγ in angiotensin II-induced vascular disease. Cardiovasc Res 97: 562-570, 2013.
13. Ji Y, Liu J, Wang Z, Liu N and Gou W: PPARgamma agonist, rosiglitazone, regulates angiotensin II-induced vascular inflammation through the TLR4-dependent signaling pathway. Lab Invest 89: 887-902, 2009.
14. Meng Z, Yu XH, Chen J, Li L and Li S: Curcumin attenuates cardiac fibrosis in spontaneously hypertensive rats through PPAR-γ activation. Acta Pharmacol Sin 35: 1247-1256, 2014.
15. Li H, Horke S and Förstermann U: Vascular oxidative stress, nitric oxide and atherosclerosis. Atherosclerosis 237: 208-219, 2014.
16. Madamanchi NR and Runge MS: NADPH oxidases and atherosclerosis: Unraveling the details. Am J Physiol Heart Circ Physiol 298: H1-H2, 2010.
17. Barry-Lane PA, Patterson C, van der Merwe M, Hu Z, Holland SM, Yeh ET and Runge MS: p47phox is required for atherosclerotic lesion progression in ApoE(-/-) mice. J Clin Invest 108: 1513-1522, 2001.
18. Kinkade K, Streeter J and Miller FJ: Inhibition of NADPH oxidase by apocynin attenuates progression of atherosclerosis. Int J Mol Sci 14: 17017-17028, 2013.
19. Goel A, Kunnumakkara AB and Aggarwal BB: Curcumin as 'Curecumin': From kitchen to clinic. Biochem Pharmacol 75: 787-809, 2008.
20. Barzegar A and Moosavi-Movahedi AA: Intracellular ROS protection efficiency and free radical-scavenging activity of curcumin. PLoS One 6: e26012, 2011.
21. Feng HL, Fan H, Dang HZ, Chen XP, Ren Y, Yang JD and Wang PW: Neuroprotective effect of curcumin to Aβ of double transgenic mice with Alzheimer's disease. Zhongguo Zhong Yao Za Zhi 39: 3846-3849, 2014 (In Chinese).
22. Sahebkar A: Dual effect of curcumin in preventing atherosclerosis: The potential role of pro-oxidant-antioxidant mechanisms. Nat Prod Res 29: 491-492, 2015.
23. Griendling KK, Taubman MB, Akers M, Mendlowitz M and Alexander RW: Characterization of phosphatidylinositol-specific phospholipase C from cultured vascular smooth muscle cells. J Biol Chem 266: 15498-15504, 1991.
24. Van Hoogmoed LM, Snyder JR and Harmon F: In vitro investigation of the effect of prostaglandins and nonsteroidal anti-inflammatory drugs on contractile activity of the equine smooth muscle of the dorsal colon, ventral colon, and pelvic flexure. Am J Vet Res 61: 1259-1266, 2000.
25. Jeong JM, Choi CH, Kang SK, Lee IH, Lee JY and Jung H: Antioxidant and chemosensitizing effects of flavonoids with hydroxy and/or methoxy groups and structure-activity relationship. J Pharm Pharm Sci 10: 537-546, 2007.
26. Mehta JL and Romeo F: Inflammation, infection and atherosclerosis: Do antibacterials have a role in the therapy of coronary artery disease? Drugs 59: 159-170, 2000.
27. Peters S: Inhibition of atherosclerosis by angiotensin II type 1 receptor antagonists. Am J Cardiovasc Drugs 13: 221-224, 2013.
28. Durante A, Peretto G, Laricchia A, Ancona F, Spartera M, Mangieri A and Cianflone D: Role of the renin-angiotensin-aldosterone system in the pathogenesis of atherosclerosis. Curr Pharm Des 18: 981-1004, 2012.
29. Fu Z, Wang M, Gucek M, Zhang J, Wu J, Jiang L, Monticone RE, Khazan B, Telljohann R, Mattison J, et al: Milk fat globule protein epidermal growth factor-8: A pivotal relay element within the angiotensin II and monocyte chemoattractant protein-1 signaling cascade mediating vascular smooth muscle cells invasion. Circ Res 104: 1337-1346, 2009.
30. Kawashima S: The two faces of endothelial nitric oxide synthase in the pathophysiology of atherosclerosis. Endothelium 11: 99-107, 2004.
31. Bunderson M, Coffin JD and Beall HD: Arsenic induces peroxynitrite generation and cyclooxygenase-2 protein expression in aortic endothelial cells: Possible role in atherosclerosis. Toxicol Appl Pharmacol 184: 11-18, 2002.
32. Detmers PA, Hernandez M, Mudgett J, Hassing H, Burton C, Mundt S, Chun S, Fletcher D, Card DJ, Lisnock J, et al: Deficiency in inducible nitric oxide synthase results in reduced atherosclerosis in apolipoprotein E-deficient mice. J Immunol 165: 3430-3435, 2000.
33. Grygiel-Górniak B: Peroxisome proliferator-activated receptors and their ligands: Nutritional and clinical implications-A review. Nutr J 13: 17, 2014.
34. Azhar S: Peroxisome proliferator-activated receptors, metabolic syndrome and cardiovascular disease. Future Cardiol 6: 657-691, 2010.
35. Matsumura T, Kinoshita H, Ishii N, Fukuda K, Motoshima H, Senokuchi T, Taketa K, Kawasaki S, Nishimaki-Mogami T, Kawada T, et al: Telmisartan exerts antiatherosclerotic effects by activating peroxisome proliferator-activated receptor-γ in macrophages. Arterioscler Thromb Vasc Biol 31: 1268-1275, 2011.
36. Siddiqui AM, Cui X, Wu R, Dong W, Zhou M, Hu M, Simms HH and Wang P: The anti-inflammatory effect of curcumin in an experimental model of sepsis is mediated by up-regulation of peroxisome proliferator-activated receptor-gamma. Crit Care Med 34: 1874-1882, 2006.
37. Ghosh SS, Massey HD, Krieg R, Fazelbhoy ZA, Ghosh S, Sica DA, Fakhry I and Gehr TW: Curcumin ameliorates renal failure in 5/6 nephrectomized rats: Role of inflammation. Am J Physiol Renal Physiol 296: F1146-F1157, 2009.
38. Fu Y, Zheng S, Lin J, Ryerse J and Chen A: Curcumin protects the rat liver from CCl4-caused injury and fibrogenesis by attenuating oxidative stress and suppressing inflammation. Mol Pharmacol 73: 399-409, 2008.
39. Tousoulis D, Psaltopoulou T, Androulakis E, Papageorgiou N, Papaioannou S, Oikonomou E, Synetos A and Stefanadis C: Oxidative stress and early atherosclerosis: Novel antioxidant treatment. Cardiovasc Drugs Ther 29: 75-88, 2015.
40. Li H, Horke S and Förstermann U: Oxidative stress in vascular disease and its pharmacological prevention. Trends Pharmacol Sci 34: 313-319, 2013.
41. Sun GB, Qin M, Ye JX, Pan RL, Meng XB, Wang M, Luo Y, Li ZY, Wang HW and Sun XB: Inhibitory effects of myricitrin on oxidative stress-induced endothelial damage and early atherosclerosis in ApoE-/-mice. Toxicol Appl Pharmacol 271: 114-126, 2013.
42. Hort MA, Straliotto MR, Netto PM, da Rocha JB, de Bem AF and Ribeiro-do-Valle RM: Diphenyl diselenide effectively reduces atherosclerotic lesions in LDLr-/-mice by attenuation of oxidative stress and inflammation. J Cardiovasc Pharmacol 58: 91-101, 2011.
43. Rong S, Zhao Y, Bao W, Xiao X, Wang D, Nussler AK, Yan H, Yao P and Liu L: Curcumin prevents chronic alcohol-induced liver disease involving decreasing ROS generation and enhancing antioxidative capacity. Phytomedicine 19: 545-550, 2012.
44. Yu W, Wu J, Cai F, Xiang J, Zha W, Fan D, Guo S, Ming Z and Liu C: Curcumin alleviates diabetic cardiomyopathy in experimental diabetic rats. PLoS One 7: e52013, 2012.
45. Bruder-Nascimento T, Chinnasamy P, Riascos-Bernal DF, Cau SB, Callera GE, Touyz RM, Tostes RC and Sibinga NE: Angiotensin II induces Fat1 expression/activation and vascular smooth muscle cell migration via Nox1-dependent reactive oxygen species generation. J Mol Cell Cardiol 66: 18-26, 2014.
46. Gray SP, Di Marco E, Okabe J, Szyndralewiez C, Heitz F, Montezano AC, de Haan JB, Koulis C, El-Osta A, Andrews KL, et al: NADPH oxidase 1 plays a key role in diabetes mellitus-accelerated atherosclerosis. Circulation 127: 1888-1902, 2013.
47. Ushio-Fukai M: Localizing NADPH oxidase-derived ROS. Sci STKE 2006: re8, 2006.
48. Zhao WC, Zhang B, Liao MJ, Zhang WX, He WY, Wang HB and Yang CX: Curcumin ameliorated diabetic neuropathy partially by inhibition of NADPH oxidase mediating oxidative stress in the spinal cord. Neurosci Lett 560: 81-85, 2014.
49. Derochette S, Franck T, Mouithys-Mickalad A, Ceusters J, Deby-Dupont G, Lejeune JP, Neven P and Serteyn D: Curcumin and resveratrol act by different ways on NADPH oxidase activity and reactive oxygen species produced by equine neutrophils. Chem Biol Interact 206: 186-193, 2013.